(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 4089.70 | 3943.10 | 3.72 | 4089.70 | 3943.10 | 3.72 | 16860.70 | 15181.90 | 11.06 |
| Other Income | 44.70 | 55.80 | -19.89 | 44.70 | 55.80 | -19.89 | 296.40 | 184.80 | 60.39 |
| PBIDT | 466.80 | 204.00 | 128.82 | 466.80 | 204.00 | 128.82 | 1867.90 | 1465.20 | 27.48 |
| Interest | 227.50 | 236.10 | -3.64 | 227.50 | 236.10 | -3.64 | 885.00 | 566.30 | 56.28 |
| PBDT | 1212.70 | -32.10 | -3877.88 | 1212.70 | -32.10 | -3877.88 | 954.30 | 908.80 | 5.01 |
| Depreciation | 280.50 | 252.00 | 11.31 | 280.50 | 252.00 | 11.31 | 1069.00 | 982.50 | 8.80 |
| PBT | 932.20 | -284.10 | -428.12 | 932.20 | -284.10 | -428.12 | -114.70 | -73.70 | 55.63 |
| TAX | 109.00 | -3.40 | -3305.88 | 109.00 | -3.40 | -3305.88 | -58.10 | 13.60 | -527.21 |
| Deferred Tax | 3.40 | -3.40 | -200.00 | 3.40 | -3.40 | -200.00 | -87.30 | 13.60 | -741.91 |
| PAT | 823.20 | -280.70 | -393.27 | 823.20 | -280.70 | -393.27 | -56.60 | -87.30 | -35.17 |
| Equity | 184.60 | 184.50 | 0.05 | 184.60 | 184.50 | 0.05 | 184.60 | 184.50 | 0.05 |
| PBIDTM(%) | 11.41 | 5.17 | 120.62 | 11.41 | 5.17 | 120.62 | 11.08 | 9.65 | 14.79 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1978.40 |
| Dr. Reddys Labs. | 1141.90 |
| Cipla | 1475.60 |
| Lupin | 2452.55 |
| Zydus Lifesciences | 1124.00 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: